ALTEOGEN Inc. (KOSDAQ:196170)
South Korea · Delayed Price · Currency is KRW 253,500
-500 (-0.20%)
Sep 18, 2026, 3:30 PM KST
ALTEOGEN Market Cap
ALTEOGEN has a market cap or net worth of 17.65 trillion as of September 18, 2026. Its market cap has decreased by -30.17% in one year.
Market Cap
17.65T
Enterprise Value
17.32T
Revenue
254.01B
Ranking
n/a
PE Ratio
97.11
Stock Price
253,500.00
ChartMarket Cap Chart
Since December 12, 2014, ALTEOGEN's market cap has increased from 119.96B to 17.65T, an increase of 14,615.06%. That is a compound annual growth rate of 52.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 17.65T | -26.57% |
| Dec 30, 2025 | 24.04T | 45.74% |
| Dec 30, 2024 | 16.49T | 221.05% |
| Dec 28, 2023 | 5.14T | 160.78% |
| Dec 29, 2022 | 1.97T | -38.41% |
| Dec 30, 2021 | 3.20T | -36.62% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.64T |
| Celltrion | 40.98T |
| Samsung Epis Holdings | 8.12T |
| SK Biopharmaceuticals | 6.08T |
| HLB Co., Ltd. | 3.94T |
| Peptron | 3.64T |
| ABL Bio | 3.14T |
| LigaChem Biosciences | 3.03T |